Jianerkang Medical Co.,Ltd. (SHA:603205)
China · Delayed Price · Currency is CNY 22.53
+0.74 (3.40%)
At close: Jun 12, 2026
Jianerkang Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 110.11 | 111.44 | 120.22 | 123.55 | 157.34 | 131.63 |
Depreciation & Amortization | 47.6 | 47.6 | 42.67 | 40.95 | 36.84 | 32.41 |
Other Amortization | 3.08 | 3.08 | 2.17 | 1.62 | 1.55 | 1.52 |
Loss (Gain) From Sale of Assets | -0.56 | -0.56 | -0.43 | -0.03 | 3.02 | -0.13 |
Asset Writedown & Restructuring Costs | 0.13 | 0.13 | 0.07 | 0.07 | 0.07 | 0.12 |
Loss (Gain) From Sale of Investments | -1.54 | -1.54 | -0.74 | 16.19 | -0.1 | -0.35 |
Provision & Write-off of Bad Debts | -0.42 | -0.42 | -0.48 | 5.95 | 14.55 | -5.5 |
Other Operating Activities | 4.59 | 14.14 | 3.78 | 0.98 | -3.29 | 7.29 |
Change in Accounts Receivable | -38.3 | -38.3 | 14.95 | -36.93 | -83.11 | -2.32 |
Change in Inventory | -1.16 | -1.16 | -25.19 | 7.31 | -17.25 | 9.65 |
Change in Accounts Payable | 21.22 | 21.22 | -21.68 | -0.9 | 46.08 | -107.28 |
Change in Other Net Operating Assets | 5.68 | 5.68 | 4.8 | -2.65 | 6.13 | 5.52 |
Operating Cash Flow | 147.92 | 158.79 | 141.1 | 157.8 | 163.01 | 70.6 |
Operating Cash Flow Growth | 27.97% | 12.54% | -10.59% | -3.20% | 130.90% | -86.25% |
Capital Expenditures | -73.03 | -69.98 | -39.75 | -84.18 | -66.32 | -48.64 |
Sale of Property, Plant & Equipment | 2.66 | 2.66 | 2.98 | 0.15 | 0.21 | 0.19 |
Sale (Purchase) of Real Estate | - | - | - | 16.3 | - | - |
Other Investing Activities | -271.08 | 0.89 | 0.26 | -16.19 | 0.1 | 0.41 |
Investing Cash Flow | -341.44 | -66.43 | -36.51 | -83.92 | -66.01 | -48.04 |
Short-Term Debt Issued | - | - | - | - | 120 | 50 |
Total Debt Issued | - | - | - | - | 120 | 50 |
Short-Term Debt Repaid | - | - | - | -30 | -140 | -69.47 |
Long-Term Debt Repaid | - | -3.05 | - | - | - | - |
Total Debt Repaid | -3.05 | -3.05 | - | -30 | -140 | -69.47 |
Net Debt Issued (Repaid) | -3.05 | -3.05 | - | -30 | -20 | -19.47 |
Issuance of Common Stock | - | - | 412.55 | - | - | 3 |
Common Dividends Paid | -42.12 | -42.12 | - | -0.69 | -1.66 | -2.1 |
Other Financing Activities | -5.58 | -2.33 | -25.1 | -2 | -2.9 | - |
Financing Cash Flow | -50.74 | -47.49 | 387.45 | -32.69 | -24.57 | -18.57 |
Foreign Exchange Rate Adjustments | -4.91 | -2.52 | 3.53 | 4.92 | 10.35 | -2.56 |
Net Cash Flow | -249.17 | 42.34 | 495.57 | 46.11 | 82.79 | 1.42 |
Free Cash Flow | 74.89 | 88.81 | 101.35 | 73.62 | 96.7 | 21.96 |
Free Cash Flow Growth | 0.15% | -12.38% | 37.66% | -23.86% | 340.34% | -94.07% |
Free Cash Flow Margin | 7.33% | 8.67% | 9.69% | 7.12% | 8.85% | 2.81% |
Free Cash Flow Per Share | 0.48 | 0.57 | 0.82 | 0.63 | 0.83 | 0.19 |
Cash Income Tax Paid | - | -47.75 | -37.42 | -48.17 | - | - |
Levered Free Cash Flow | 42.78 | 55.42 | 55.45 | 12.35 | 32.97 | -46.43 |
Unlevered Free Cash Flow | 43.75 | 56.14 | 55.45 | 12.76 | 34 | -45.13 |
Change in Working Capital | -15.08 | -15.08 | -26.15 | -31.47 | -46.97 | -96.39 |